AHA Study Links Energy Drinks to 11x Higher Cardiac Arrest Reports in Young Adults

Key points

• Analysis of 28,345 FDA reports from 2017 to 2025 shows cardiac arrest is 11 times more likely in reports involving stimulant products.
• Heart attacks are 4.5 times more likely, and abnormal rhythms are 4 times more likely in these reports compared to non-stimulant products.
• Approximately 45% of these cardiovascular event reports involved adults aged 18 to 34.
• The AHA recommends a daily caffeine limit of 400 mg, which can be exceeded by one or two energy drinks or pre-workout supplements.
• Researchers emphasize that the study shows association, not causation, and notes that voluntary reporting may limit data accuracy.

Background

This finding follows earlier coverage of the same AHA Scientific Sessions 2026 data, which highlighted similar associations between stimulant products and cardiac risks. It also aligns with recent industry lawsuits regarding energy drink safety, such as cases involving Alani Nu and Panera, which have raised public awareness about potential cardiovascular harms from high caffeine intake.

How outlets are covering it

While all sources agree on the statistical associations, they differ in emphasis. Fox 13 and USA Today focus on the public health warning and the need for consumers to track intake. Fox News highlights expert opinions from cardiologists like Colin Kane, who notes that people with undiagnosed heart conditions are at higher risk. The American Beverage Association and Council for Responsible Nutrition push back, arguing that the study does not account for total consumption or misuse, and that moderate caffeine intake is safe. Medical News Today emphasizes the limitations of observational data and the need for further peer-reviewed research to establish causation.

Why it matters

Young adults are disproportionately represented in these reports, suggesting a potential public health concern. As energy drink sales exceed $20 billion annually, understanding the risks of high caffeine and stimulant intake is crucial for consumer safety and healthcare provider awareness.

What to watch

The AHA will present the full findings at its Scientific Sessions in Chicago from November 6 to 9, 2026. Researchers call for more rigorous studies to determine if these products directly cause heart events and to identify specific risk thresholds for different populations.